New Delhi, February 24 Alembic Pharmaceuticals announced on Tuesday that it has received approval from the US health regulator to market a generic antifungal medication.The company has received final approval from the US Food & Drug Administration (USFDA) for Efinaconazole Topical Solution...
alembic pharmaceuticals
anda
antifungal medication
bausch health americas, inc.
bse
efinaconazole topicalsolution
generic medication
jubliatopicalsolution
market size
onychomycosis
pharmaceutical industry
topicalsolution
trichophyton mentagrophytes
trichophyton rubrum
us food & drug administration